Finance

Lists
1752:TPE
Nang Kuang Pharmaceutical Co Ltd
NT$30.10
+0.33%
(+0.10) 1D
Nov 13, 1:30:05 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1752...
Open
NT$30.00
High
NT$30.25
Low
NT$30.00
Mkt. cap
3.04B
Avg. vol.
96.74K
Volume
26.42K
Dividend
5.32%
Quarterly dividend
NT$0.40
Ex-dividend date
Jul 2, 2026
P/E ratio
14.83
52-wk high
NT$38.95
52-wk low
NT$28.95
EPS
NT$2.03
No. of employees
552
Open
NT$30.00
High
NT$30.25
Low
NT$30.00
Mkt. cap
3.04B
Avg. vol.
96.74K
Volume
26.42K
Dividend
5.32%
Quarterly dividend
NT$0.40
Ex-dividend date
Jul 2, 2026
P/E ratio
14.83
52-wk high
NT$38.95
52-wk low
NT$28.95
EPS
NT$2.03
No. of employees
552
News stories
From web sources and news partners
About Nang Kuang Pharmaceutical Co Ltd
CEO-
Employees552
Founded1963
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
517.20M
529.63M
538.59M
503.08M
Cost of goods sold
336.54M
342.12M
340.37M
346.41M
Cost of revenue
336.54M
342.12M
340.37M
346.41M
Research and development expenses
38.21M
38.12M
44.63M
36.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
79.31M
78.63M
77.50M
76.94M
Operating expense
117.52M
116.75M
122.14M
113.26M
Total operating expenses
454.06M
458.87M
462.52M
459.67M
Operating income
63.13M
70.76M
76.07M
43.40M
Other non operating income
5.33M
2.12M
2.23M
-3.66M
EBT including unusual items
76.32M
45.21M
64.37M
37.70M
EBT excluding unusual items
71.02M
72.46M
75.64M
37.70M
Income tax expense
2.97M
13.19M
12.63M
8.64M
Effective tax rate
3.90%
29.17%
19.62%
22.91%
Other operating expenses
-
-
-
-
Net income
73.82M
32.56M
52.37M
29.56M
Net profit margin
14.27%
6.15%
9.72%
5.88%
Earnings per share
-
-
-
-
Interest and investment income
1.11M
576.00K
1.02M
433.00K
Interest expense
-2.39M
-2.26M
-2.04M
-2.47M
Net interest expenses
-1.28M
-1.68M
-1.02M
-2.04M
Depreciation and amortization charges
-
-
-
-
EBITDA
107.78M
115.20M
121.10M
90.55M
Gain or loss from assets sale
-
-
-
-436.00K
Upcoming events
AI content may include mistakes. Learn more
Google apps